Partner, Teddy Lab, selected as central lab for Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

We are proud to announce that our partner in China, Teddy Lab, has been selected as the authorized central lab for a Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. On March 18th, the results were published in the New England Journal of Medicine (NJEM).

Read the full article here.

Back to News and Events